Nephros (NEPH) Depreciation & Amortization (CF) (2010 - 2026)

Nephros' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $11000.0 for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 35.29% year-over-year to $11000.0 in Q1 2026; TTM through Mar 2026 was $49000.0, a 5.77% decrease from a year earlier, with the FY2025 full-year figure at $55000.0, up 19.57% from the prior year.
• Depreciation & Amortization (CF) slipped to $11000.0 in Q1 2026 per NEPH's latest filing, from $13000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $36000.0 in Q2 2022 and bottomed at $9000.0 in Q2 2023.
• The 5-year median for Depreciation & Amortization (CF) is $12000.0 (2024), against an average of $14352.9.
• Across the five-year window, Depreciation & Amortization (CF) jumped 350.0% in 2022 and sank 75.0% in 2023, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $11000.0 in 2022, then declined by 9.09% to $10000.0 in 2023, then gained by 20.0% to $12000.0 in 2024, then grew by 8.33% to $13000.0 in 2025, then slipped by 15.38% to $11000.0 in 2026.
• Per Business Quant, the three latest NEPH Depreciation & Amortization (CF) figures stand at $11000.0 (Q1 2026), $13000.0 (Q4 2025), and $12000.0 (Q3 2025).